PIN1 and pulmonary arterial hypertension: We conclude that inhibition of Pin1 displays beneficial effects in vitro and in vivo, and the development of a more selective Pin1 inhibitor might be beneficial (either alone or in combination with existing therapeutic approaches) for treating this deadly disease PAH.